Kevin Bullaughey is a Senior Scientist at Century Therapeutics, Inc. Kevin has a strong background in data analysis, specializing in single cell genomics analysis. Kevin is also a founder and principal scientist at DataHelix LLC, where Kevin helps early stage biotech companies with their data analysis objectives. Prior to this, Kevin founded WordSwing, an online service for learning Mandarin Chinese, and worked as the Chief Scientific Officer at Genome Appliances. Kevin holds a PhD in Evolutionary Biology from the University of Chicago and a Bachelor's degree in Computer Science and Biology from the University of Pennsylvania.
July, 2023 - present